Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > $TLTFF

<< Previous

Bullboard Posts

Next >>

Comment by floatinketuckyon Feb 17, 2022 7:41am

454 Views

Post# 34437226

RE:$TLTFF

Picked up more Good CR from 1 of 2.
12 -4=8-2=6 patinetes to get second dose full.
maybe we get 3 of 6 back from our first dozen. yep yep

Note: There are 2 patients that received an unoptimized primary Study II Treatment and were diagnosed as non-responsive; however, they then received an optimized maintenance Study II Treatment. Analyzing these 2 patients, 1 remained non-responsive and 1 achieved a CR at 270 days and PR at 360 and 450 days, respectively.

As of November 29, 2021

Quarterly Newsletter 2Q2021 (theralase.com)

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario